SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-018995
Filing Date
2024-03-01
Accepted
2024-03-01 16:05:38
Documents
17
Period of Report
2024-02-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201008-8k_virpaxphrm.htm   iXBRL 8-K 51013
2 CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATIO ea0201008ex3-1_virpax.htm EX-3.1 11726
3 SETTLEMENT AGREEMENT AND MUTUAL RELEASE BETWEEN VIRPAX PHARMACEUTICALS, INC. AND ea0201008ex10-1_virpax.htm EX-10.1 59544
4 PRESS RELEASE OF VIRPAX PHARMACEUTICALS, INC., DATED FEBRUARY 27, 2024 ea0201008ex99-1_virpax.htm EX-99.1 19026
  Complete submission text file 0001213900-24-018995.txt   345391

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vrpx-20240229.xsd EX-101.SCH 3027
6 XBRL LABEL FILE vrpx-20240229_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE vrpx-20240229_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0201008-8k_virpaxphrm_htm.xml XML 3850
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 24709597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)